Clinical Trials Browser

Phase 3 × Breast Neoplasms × Octreotide × Clear all

NCT00002864 2020-04-01

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3 Completed

Breast Neoplasms